1. Dopichaj-Menge U, Ivancevic V, Kettner B, Munz DL. Does duration of fasting influence the intensity of non-specific bowel activity in FDG-PET? [abstract]. Eur J Nucl Med 2000;27(8):1008.
2. Steinmetz AP, Cronin B, Wierzbicki AS, Lumb PJ, Maisey MN. Relation-ship of myocardial 18-FDG uptake in oncologic PET imaging to plasma lipid and glucose metabolism [abstract]. Eur J Nucl Med 2000;27(8):902.
3. Engel H, Steinert H, Buck A, Berthold T, Huch Boni RA, von Schulthess GK. Whole-body PET: physiological and artefactual fluorodeoxyglucose accumulations. J Nucl Med 1996;37(3):441?6.
4. Cook GJ, Fogelman I, Maisey MN. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning potential for error in interpretation. Semin Nucl Med 1996;26(4):308?14.
5. Hany TF, Gharehpapagh E, Kamel EM, Buck A, Himms-Hagen J, von Schulthess K. Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region. Eur J Nucl Med 2002;29(10):1393?8.